Sanofi
SNY
$48.66
$0.310.64%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 43.37B | 38.85B | |
| Total Other Revenue | -- | -- | 3.38B | 3.81B | |
| Total Revenue | -- | -- | 46.75B | 42.66B | |
| Cost of Revenue | -- | -- | 13.92B | 12.94B | |
| Gross Profit | -- | -- | 32.83B | 29.72B | |
| SG&A Expenses | -- | -- | 9.80B | 8.37B | |
| Depreciation & Amortization | -- | -- | 1.84B | 1.73B | |
| Other Operating Expenses | -- | -- | 3.68B | 4.58B | |
| Total Operating Expenses | -- | -- | 37.05B | 34.91B | |
| Operating Income | -- | -- | 9.70B | 7.75B | |
| Income Before Tax | -- | -- | 7.15B | 5.11B | |
| Income Tax Expenses | -- | -- | 1.27B | 847.46M | |
| Earnings from Continuing Operations | -- | -- | 5.87K | 4.27K | |
| Earnings from Discontinued Operations | -- | -- | 63.57M | 261.39M | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -61.43M | -46.49M | |
| Net Income | -- | -- | 5.88B | 4.84B | |
| EBIT | -- | -- | 9.70B | 7.75B | |
| EBITDA | -- | -- | 13.80B | 11.02B | |
| EPS Basic | -- | -- | 4.69 | 3.87 | |
| Normalized Basic EPS | -- | -- | -- | -- | |
| EPS Diluted | -- | -- | 4.68 | 3.86 | |
| Normalized Diluted EPS | -- | -- | -- | -- | |
| Average Basic Shares Outstanding | -- | -- | 5.00B | 5.00B | |
| Average Diluted Shares Outstanding | -- | -- | 5.01B | 5.01B | |
| Dividend Per Share | -- | -- | 4.18 | 4.05 | |
| Payout Ratio | -- | -- | -- | -- | |